openPR Logo
Press release

Weitz & Luxenberg Responds to Report Calling Medical Malpractice Lawsuit Crisis a 'Hoax'

01-25-2007 10:22 AM CET | Politics, Law & Society

Press release from: Weitz & Luxenberg

A leading plaintiffs', mass torts, medical malpractice and personal injury litigation law firm in America

A leading plaintiffs', mass torts, medical malpractice and personal injury litigation law firm in America

January 24, 2007, New York, NY—The belief that the United States is in the throes of a medical malpractice lawsuit crisis can be blamed on just a tiny group of negligent doctors, says a new watchdog report.

According to “The Great Medical Malpractice Hoax,” released by Ralph Nader’s Public Citizen group, just 5.9 percent of doctors have been responsible for 57.8 percent of all medical malpractice payments, as of research spanning 1990 through 2005. The study found that each of these doctors made a least two payments, while conversely, the vast majority of physicians—82 percent—have never even had a medical malpractice payment.

“We've been telling the legislature and the public about this for years. Now we finally have the data to prove it,” said Allan Zelikovic, head of the Medical Malpractice Unit at Weitz & Luxenberg. Zelikovic’s cases include one involving a girl who suffered brain damage at birth due to appalling substandard medical care. The monetary award derived from that case is now used by her mother to help mitigate the overwhelming cost of caring for her for the rest of her life.

The study concerned itself with such negligence, with researchers analyzing data from the National Practitioner Data Bank Public Use File. Part I of the analysis shows that the claims of business and medical lobbies are “exaggerated and unsupported by the facts.”

Part II examines data related to physician error and discipline, finding that “the real medical malpractice crisis continues to be inadequate patient safety, rather than the legal system.” The report claims that there is a grievous lack of accountability on the part of a small group of doctors who commit a substantial number of avoidable errors that seriously injure patients.

The report contends that the business lobby seeks to protect its interests and distract people from medical negligence by calling for limits on malpractice litigation.
Health care providers, said the report, would be better served by striving to improve patient safety than giving credence to myths perpetuated about the court system.

About Weitz & Luxenberg
Weitz & Luxenberg, founded in 1986, is one of the leading plaintiffs’, mass torts, medical malpractice and personal injury litigation law firms in America. The firm has played leading roles in national and local litigations involving asbestos, DES, and silicone breast implants, among others. A forerunner in the legal fight against environmental polluters, Weitz & Luxenberg has worked with clients harmed by MTBE and mercury, among other toxins. The firm has won numerous cases involving dangerous pharmaceuticals, including Vioxx, achieving a $13.5 million verdict against Merck & Co. (docket No. ATLL129605).

Those who have been affected by medical malpractice may contact Weitz & Luxenberg by calling our Client Relations Department at 800-476-6070 or e-mailing clientrelations@weitzlux.com. Please also visit our website: www.weitzlux.com

Weitz & Luxenberg
180 Maiden Lane
New York, NY 10038

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Weitz & Luxenberg Responds to Report Calling Medical Malpractice Lawsuit Crisis a 'Hoax' here

News-ID: 14891 • Views:

More Releases from Weitz & Luxenberg

Weitz & Luxenberg Cited for Top NYS 2014 Product Liability Cases by New York Law …
Weitz & Luxenberg, P.C. has been recognized by the New York Law Journal for winning the top three product liability verdicts in New York State in 2014. “The lawyers and law firms who are ranked in this special section represent the best of the best in 2014,” New York Law Journal associate publisher Farrell McManus wrote in the Journal’s “Top Verdicts New York 2014.” He continued, “Their zealous advocacy on
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma Treatment Tomudex Receives International Support
Mesothelioma treatment Tomudex, made by a global pharmaceutical company, is receiving approval from a panel of international experts. Tomudex falls in the group of anti-cancer drugs known as antineoplastics. It prevents cell growth. By doing so, it leads to the elimination of tumors. In a study examining people diagnosed with pleural mesothelioma, the use of Tomudex in conjunction with Platinol resulted in improved response rates of 23.6% as opposed to
New Mesothelioma Treatment Technique Developed
New Mesothelioma Treatment Technique Developed
Extrapleural pneumonectomy, a surgical procedure that removes mesothelioma cancer from the lining of the lung, has been reported to be an effective new mesothelioma treatment technique. The technique was developed by Dr. Sugarbaker, the co-leader of the Brigham Biomedical Research Institute's Cancer Research Center, Chief of the Institute's Division of Thoracic Surgery and a Professor of Oncologic Surgery at Harvard Medical School. The surgical technique was applied on a mesothelioma patient
Mesothelioma Cancer: Possible Treatment Option
Mesothelioma Cancer: Possible Treatment Option
An experiment carried out in Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and the Medical University Vienna has tested the effectiveness of a genetically modified virus to treat mesothelioma in animals. The virus is known as Newcastle Disease Virus (NDV). Animals with mesothelioma administered with multiple doses of NDV responded better than those that received a single dose. The use of a genetically engineered virus to disrupt the function

All 5 Releases


More Releases for America

Waterproof Labels Market Outlook, Supportive Judgments | SATO America, LANGGUTH …
Report Ocean recently published a new report on the Global Waterproof Labels Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Waterproof Labels Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Waterproof Labels Market situation of the leading key players, key market trends, and potential
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Blow Molding Machinery Market Analysis Report, Regional Outlook - Europe, North …
Adroit Market Research has announced the addition of the “Global Blow Molding Machinery Market Size Status and Forecast 2025”, The report classifies the global Blow Molding Machinery in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Blow Molding Machinery Speaker market, analyzes and researches the Blow Molding Machinery Speaker development status and forecast in Europe,
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Spas and Beauty Salons Market - South America, Central America and North America …
Consumers’ changing perception towards personal care coupled with continuous strive to improve general well-being are generating a positive impact on the spas and beauty salons industry. Growing consumer need to improve personal appearance and well-being has increased the demand for wellness solutions. Spa centers and beauty salons, in order to meet the increasing demand for unique spa and beauty services, are constantly striving to improve their services by focusing on